HFX™ is a breakthrough for those struggling with chronic painful diabetic neuropathy, which is a condition that can occur in patients with diabetes. This newly and only FDA-approved treatment option provides innovative treatment for the pain associated with the condition. The treatment uses spinal cord stimulation, or SCS, to provide pain relief.
Until recently, there has been a lack of effective options for those dealing with chronic painful diabetic neuropathy. Spinal cord stimulation has been used for decades to treat chronic pain, but the treatment may cause paresthesia, which is a tingling or prickling sensation. HFX™ for painful diabetic neuropathy, or PDN, is a new safe and effective option that treats the pain associated with diabetic neuropathy. The system works by using a new 10 kHz high-frequency spinal cord stimulation therapy to deliver electrical energy around the spine, providing pain relief without discomfort.
If you’re struggling with chronic painful diabetic neuropathy you may be significantly impacted by the condition due to the pain, numbness, or burning sensation it can cause in the feet. HFX™ for PDN relieves pain so that patients can more fully enjoy their day-to-day lives without worrying about the limitations that the condition causes.
In this randomized clinical trial including 216 patients, there was a significant benefit of 10-kHz spinal cord stimulation, with 79% of treatment responders whose underlying neurological deficits did not worsen compared with 5% of controls treated with conventional medical management. The pain scores of patients who were treated with conventional medical management did not, on average, change significantly, the overall improvement of pain scores with HFX was nearly 80%.
85% of people enjoy long-term pain relief
Reduce your pain and improve your sleep